一种靶向中东呼吸综合征冠状病毒刺突蛋白N端结构域的新型中和单克隆抗体。
A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.
作者信息
Chen Yingzhu, Lu Shuai, Jia Hao, Deng Yao, Zhou Jianfang, Huang Baoying, Yu Yueyang, Lan Jiaming, Wang Wenling, Lou Yongliang, Qin Kun, Tan Wenjie
机构信息
School of Laboratory Medicine and Life Science, Institute of Medical Virology, Wenzhou Medical University, Wenzhou 325035, China.
Key Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China.
出版信息
Emerg Microbes Infect. 2017 Jun 28;6(6):e60. doi: 10.1038/emi.2017.50.
Abstract
This corrects the article DOI: 10.1038/emi.2017.18.
摘要
这更正了文章的数字对象标识符
10.1038/emi.2017.18 。
相似文献
1
A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.一种靶向中东呼吸综合征冠状病毒刺突蛋白N端结构域的新型中和单克隆抗体。
Emerg Microbes Infect. 2017 Jun 28;6(6):e60. doi: 10.1038/emi.2017.50.
2
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.一种新型针对中东呼吸综合征冠状病毒（MERS-CoV）受体结合域的纳米抗体具有强大的交叉中和活性和针对 MERS-CoV 的保护效力。
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00837-18. Print 2018 Sep 15.
3
MERS-CoV spike protein: a key target for antivirals.中东呼吸综合征冠状病毒刺突蛋白：抗病毒药物的关键靶点。
Expert Opin Ther Targets. 2017 Feb;21(2):131-143. doi: 10.1080/14728222.2017.1271415. Epub 2016 Dec 21.
4
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.一种针对中东呼吸综合征冠状病毒（MERS-CoV）的人源化中和抗体，靶向刺突蛋白的受体结合结构域。
Cell Res. 2015 Nov;25(11):1237-49. doi: 10.1038/cr.2015.113. Epub 2015 Sep 22.
5
Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.人源中和单克隆抗体对病毒刺突糖蛋白的强力中和作用可有效抑制中东呼吸综合征冠状病毒。
Sci Transl Med. 2014 Apr 30;6(234):234ra59. doi: 10.1126/scitranslmed.3008140. Epub 2014 Apr 28.
6
A phylogenetically distinct Middle East respiratory syndrome coronavirus detected in a dromedary calf from a closed dairy herd in Dubai with rising seroprevalence with age.在迪拜一个封闭奶牛场的一头单峰骆驼幼崽中检测到一种系统发育上独特的中东呼吸综合征冠状病毒，其血清阳性率随年龄增长而上升。
Emerg Microbes Infect. 2015 Dec 2;4(12):e74. doi: 10.1038/emi.2015.74.
7
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.一种强效人源单克隆抗体对中东呼吸综合征冠状病毒的预防及暴露后疗效
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10473-8. doi: 10.1073/pnas.1510199112. Epub 2015 Jul 27.
8
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.具有最佳免疫原剂量和免疫间隔的中东呼吸综合征冠状病毒受体结合域可保护人类转基因小鼠免受中东呼吸综合征冠状病毒感染。
Hum Vaccin Immunother. 2017 Jul 3;13(7):1615-1624. doi: 10.1080/21645515.2017.1296994. Epub 2017 Mar 9.
9
Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines.更正：中东呼吸综合征冠状病毒刺突蛋白的截短受体结合域可有效抑制中东呼吸综合征冠状病毒感染并诱导强烈的中和抗体反应：对开发治疗方法和疫苗的启示
PLoS One. 2022 Dec 5;17(12):e0278474. doi: 10.1371/journal.pone.0278474. eCollection 2022.
10
Evaluation of candidate vaccine approaches for MERS-CoV.中东呼吸综合征冠状病毒候选疫苗方法的评估
Nat Commun. 2015 Jul 28;6:7712. doi: 10.1038/ncomms8712.
引用本文的文献
1
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV.蛋白质纳米颗粒疫苗可诱导针对中东呼吸综合征冠状病毒（MERS-CoV）产生有效的中和抗体反应。
Cell Rep. 2024 Dec 24;43(12):115036. doi: 10.1016/j.celrep.2024.115036. Epub 2024 Dec 6.
2
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV.蛋白质纳米颗粒疫苗可诱导针对中东呼吸综合征冠状病毒（MERS-CoV）产生有效的中和抗体反应。
bioRxiv. 2024 Mar 14:2024.03.13.584735. doi: 10.1101/2024.03.13.584735.
3
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection.冠状病毒刺突蛋白中保守区域对研发抗SARS-CoV-2感染新型疫苗的意义
Vaccines (Basel). 2023 Feb 24;11(3):545. doi: 10.3390/vaccines11030545.
4
RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2.RBD 和 Spike 基于 DNA 的免疫接种在兔子中引起 IgG 亲和力成熟和针对 SARS-CoV-2 的高中和抗体反应。
Viruses. 2023 Feb 17;15(2):555. doi: 10.3390/v15020555.
5
Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein.与中东呼吸综合征冠状病毒刺突糖蛋白结合的人源中和抗体的冷冻电镜结构
Front Microbiol. 2022 Sep 28;13:988298. doi: 10.3389/fmicb.2022.988298. eCollection 2022.
6
Vaccination in patients with kidney failure: lessons from COVID-19.肾衰竭患者的疫苗接种：COVID-19 带来的启示。
Nat Rev Nephrol. 2022 Nov;18(11):708-723. doi: 10.1038/s41581-022-00617-5. Epub 2022 Aug 23.
7
The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections.一种新型针对刺突蛋白的抗体结构可抑制中东呼吸综合征冠状病毒感染。
Sci Rep. 2022 Jan 24;12(1):1260. doi: 10.1038/s41598-022-05318-4.
8
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses.针对高致病性冠状病毒的中和单克隆抗体。
Curr Opin Virol. 2022 Apr;53:101199. doi: 10.1016/j.coviro.2021.12.015. Epub 2021 Dec 30.
9
Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients.基于纳米技术的方法在控制新冠疫情中的重要性日益凸显；聚焦纳米医学在新冠患者诊断和治疗中的迭代应用。
J Drug Deliv Sci Technol. 2022 Jan;67:102967. doi: 10.1016/j.jddst.2021.102967. Epub 2021 Nov 6.
10
SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development.用于新冠诊断和疫苗研发的严重急性呼吸综合征冠状病毒2刺突蛋白推断法
Front Mol Biosci. 2021 Jul 28;8:607886. doi: 10.3389/fmolb.2021.607886. eCollection 2021.
Zotero 插件